Abstract
Genomic technology presents new and exciting opportunities to study complex human diseases. Several types of genomic analysis are helping to elucidate the biology of important human cancers. One of these, gene expression profiling, provides a more comprehensive view of the consequences of the genetic changes in cancer cells than was previously available. In addition to detailing the expression patterns of thousands of genes simultaneously, this exploding field of research has begun to build a new ‘molecular taxonomy’ of cancer and to identify novel disease genes for many human cancers, including cutaneous melanoma. Whether this new information will lead to improved treatments and prolonged survival for cancer patients remains to be determined. Here, we review the use of complementary DNA microarray technology to study gene expression patterns in cutaneous melanoma and highlight recent advances concerning the identification of novel melanoma disease-related genes. The fundamentals of microarray technology and analysis have been extensively discussed, and readers are referred to several recent reviews in this area.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Bryd JC, Botstein D, Brown PO and Staudt LM . (2000). Nature, 403, 503–511.
Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V, Hayward N and Trent J . (2000). Nature, 406, 536–540.
Clark EA, Golub TR, Lander ES and Hynes RO . (2002). Nature, 406, 532–535.
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA . (2002). Nature, 417, 949–954.
DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA and Trent JM . (1996). Nat. Genet., 14, 457–460.
Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA and Chinnaiyan AM . (2001). Nature, 412, 822–826.
Duggan DJ, Bittner M, Chen Y, Meltzer P and Trent JM . (1999). Nat. Genet., 21, 10–14.
Jansen B, Wacheck V, Heere-Ress E, Schlagbauer-Wadl H, Hoeller C, Lucas T, Hoermann M, Hollenstein U, Wolff K and Pehamberger H . (2000). Lancet, 356, 1728–1733.
Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C and Meltzer PS . (2001). Nat. Med., 7, 673–679.
King R, Weilbaecher KN, McGill G, Cooley E, Mihm M and Fisher DE . (1999). Am. J. Pathol., 155, 731–738.
Lotze MT, Chang AE, Seipp CA, Simpson C, Vetto JT and Rosenberg SA . (1986). JAMA, 256, 3117–3124.
MacDonald TJ, Brown KM, LaFleur B, Peterson K, Lawlor C, Chen Y, Packer RJ, Cogen P and Stephan DA . (2001). Nat. Genet., 29, 143–152.
McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK, Lin YL, Ramaswamy S, Avery W, Ding HF, Jordan SA, Jackson IJ, Korsmeyer SJ, Golub TR and Fisher DE . (2002). Cell, 109, 707–718.
Palmantier R, George MD, Akiyama SK, Wolber FM, Olden K and Roberts JD . (2001). Cancer Res., 61, 2445–2452.
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D . (2000). Nature, 406, 747–752.
Quackenbush J (2001). Nat. Rev. Genet., 2, 418–427.
Ramaswamy S and Golub TR . (2002). J. Clin. Oncol., 20, 1932–1941.
Ridley AJ . (2001). Trends Cell Biol., 11, 471–477
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L and Edwards BK . (2001). SEER Cancer Statistics Review, 1973–1998, Vol. 2001, National Cancer Institute: Bethesda, MD, USA.
Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG and White DE . (1987). N. Engl. J. Med., 316, 889–897.
Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA and Reichert CM . (1987). N. Engl. J. Med., 313, 1485–1492.
Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink K, Smeland EB and Staudt LM . (2002). N. Engl. J. Med., 346, 1937–1947.
Sahai E and Marshall CJ . (2002). Nat. Rev. Cancer, 2, 133–142.
Schena M, Shalon D, Davis RW and Brown PO . (1995). Science, 270, 467–470.
Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC and Golub TR . (2002). Nat. Med., 8, 68–74.
Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P and Borresen-Dale AL . (2001). Proc. Natl. Acad. Sci. USA, 98, 10869–10874.
van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH . (2002). Nature, 415, 530–536.
Wang E, Miller LD, Ohnmacht GA, Mocellin S, Perez-Diez A, Petersen D, Zhao Y, Simon R, Powell JI, Asaki E, Alexander HR, Duray PH, Herlyn M, Restifo NP, Liu ET, Rosenberg SA and Marincola FM . (2002). Cancer Res., 62, 3581–3586.
Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M and Trent JM . (2002). Cancer Cell, 1, 279–288.
Yuan J, Slice L, Walsh JH and Rozengurt E . (2000). J. Biol. Chem., 275, 2157–2164.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carr, K., Bittner, M. & Trent, J. Gene-expression profiling in human cutaneous melanoma. Oncogene 22, 3076–3080 (2003). https://doi.org/10.1038/sj.onc.1206448
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206448
Keywords
This article is cited by
-
RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target
Journal of Experimental & Clinical Cancer Research (2019)
-
Plasticity underlies tumor progression: role of Nodal signaling
Cancer and Metastasis Reviews (2016)
-
Molecular changes induced by the curcumin analogue D6 in human melanoma cells
Molecular Cancer (2013)
-
Genome-wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation network
Scientific Reports (2013)
-
Molekulargenetik in der dermatologischen Diagnostik
Der Hautarzt (2012)